Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Biomind Labs Inc N.BMND

Alternate Symbol(s):  BMNDF

Biomind Labs Inc. is a biotech research and development company. It is focused on transforming biomedical sciences knowledge into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Through its acceleration platform, Biomind Labs is developing novel pharmaceutical formulations of key endogenous substances which are occurring in the human body and an organic compound that includes many neurotransmitters for treating a range of therapeutic indications. DMT is a serotonergic psychedelic that exerts its effects through serotonergic receptors in the brain, including 5-HT2A, 5-HT1A, 5-HT2C and 5-HT7 receptors. 5-MeO-DMT is a powerful psychedelic tryptamine. Under the 5-MeO-DMT Program, it is focused on two drug candidates: BMND05: 5-MeO-DMT novel formulation indicated for Chronic Pain and BMND08: 5-MeO-DMT novel formulation indicated for Alzheimer’s disease. Mescaline is a psychedelic alkaloid of the phenethylamine class.


NEO:BMND - Post by User

Bullboard Posts
Comment by DTM5on Dec 06, 2009 10:09pm
240 Views
Post# 16559481

RE: $1.60 is where this will end up getting taken

RE: $1.60 is where this will end up getting takenLikely good advice Medicine Hat.  If this is going to be sold, your rationale makes sense.  I still think (Hope?) that the management here is thinking long term and their plans have been decimated by the markets over the past year - And that is 2010 they'll be back on track and in 2011 we'll be looking at a very different scenario.
I've been through this type of thing as well.  I expected Driscoll and the team to try to take it private at about $1.60 - $1.80 - A defensible price - Hence the continual buying.   I almost expect to be ripped off by majority shareholders!
Problem now becomes the smell around the company.  A failed takeover, management who isn't communicative and rable rousing shareholders with their own agendas does not a happy story make.
Bullboard Posts